Cabaletta Bio (CABA)
3.28
+0.03 (0.92%)
Upcoming Events
Latest Headlines
TD Cowen Assumes Cabaletta Bio (CABA) at Buy
August 22, 2026 7:55 AM - StreetInsider
Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: Cormorant Asset Management, LP
August 14, 2026 2:01 PM - SEC Filing
Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: T. Rowe Price Investment Management, Inc.
August 14, 2026 10:40 AM - SEC Filing
Cabaletta Bio (CABA) PT Lowered to $3 at Wells Fargo
August 14, 2026 8:51 AM - StreetInsider
Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP
August 14, 2026 7:00 AM - SEC Filing
TD Cowen: 'CABA appears well-positioned to scale commercially with minimal capital investment'
August 13, 2026 10:32 AM - StreetInsider
Form 10-Q Cabaletta Bio, Inc. For: Jun 30
August 13, 2026 7:35 AM - SEC Filing
Form 8-K Cabaletta Bio, Inc. For: Aug 13
August 13, 2026 7:32 AM - SEC Filing
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026 7:30 AM - StreetInsider
Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: Adage Capital Management, L.P.
August 12, 2026 12:06 PM - SEC Filing
Form SCHEDULE 13G Cabaletta Bio, Inc. Filed by: NORGES BANK
August 12, 2026 6:36 AM - SEC Filing
Form SCHEDULE 13G Cabaletta Bio, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC
July 31, 2026 9:55 AM - SEC Filing
Form SCHEDULE 13G Cabaletta Bio, Inc. Filed by: BlackRock, Inc.
July 27, 2026 4:27 PM - SEC Filing
Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: MILLENNIUM MANAGEMENT LLC
July 23, 2026 5:28 PM - SEC Filing
Increasing unusual call option volume: GDS AM PGEN DFTX CTSH SWKS AIG BFLY OTLK EH CABA
June 23, 2026 3:36 AM - StreetInsider
Form 8-K Cabaletta Bio, Inc. For: Jun 09
June 11, 2026 7:01 AM - SEC Filing
Form 4 Cabaletta Bio, Inc. For: Jun 09 Filed by: Tomasello Shawn
June 10, 2026 7:04 PM - SEC Filing
Form 4 Cabaletta Bio, Inc. For: Jun 09 Filed by: Simon Mark
June 10, 2026 7:00 PM - SEC Filing
Form 4 Cabaletta Bio, Inc. For: Jun 09 Filed by: HENRIQUES RICHARD C JR
June 10, 2026 6:56 PM - SEC Filing
Form 4 Cabaletta Bio, Inc. For: Jun 09 Filed by: Bollard Catherine
June 10, 2026 6:54 PM - SEC Filing
Form 4 Cabaletta Bio, Inc. For: Jun 09 Filed by: Brun Scott C.
June 10, 2026 6:51 PM - SEC Filing
Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: PRUDENTIAL FINANCIAL INC
June 5, 2026 2:10 PM - SEC Filing
Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: JENNISON ASSOCIATES LLC
June 4, 2026 4:18 PM - SEC Filing
Jefferies on Cabaletta Bio (CABA): 'We came away from EULAR 2026 update increasingly positive on the wholistic resecel profile'
June 3, 2026 7:31 AM - StreetInsider
Cabaletta Bio reports positive rese-cel data in autoimmune diseases
June 3, 2026 7:03 AM - StreetInsider
Form 8-K Cabaletta Bio, Inc. For: Jun 03
June 3, 2026 7:02 AM - SEC Filing
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
June 3, 2026 7:00 AM - StreetInsider
Form DEFA14A Cabaletta Bio, Inc.
June 1, 2026 7:30 AM - SEC Filing
Full Article List
